Physician
Oncology
Dr. Marshall T. Schreeder, MD
|
|
Give Review
Marshall Schreeder works in the field of Oncology. He attended Tulane University School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Marshall T. Schreeder, MD is also published. He has 33 publications published. The lastest publication: "Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.' He is registered with Medicare and accepts Medicare payments.
Publications
- Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung Cancer.
- A novel five-antibody immunohistochemical test for subclassification of lung Carcinoma.
- Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung Cancer: a multicenter phase 2 study.
- Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic Leukemia and small lymphocytic lymphoma.
- A phase I trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-sta...
- Clinical experience with ciprofloxacin: Analysis of a multicenter study.
- Mucormycosis: a community hospital perspective.
- Letter: Chezonisus and defecation:symptoms of Acute myocardial infarction.
- Dialysis encephalopathy.
- The transplanted kidney as a source of hepatitis B infection.
- Multiple buoyant densities of hepatitis A virus in cesium chloride gradients.
- Carcinoma of unknown primary site.
- Hepatic artery administration of paclitaxel.
- Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide.
- A prospective study of hepatitis B virus serologic markers and Liver enzymes.
- Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus.
- EEG in dialysis encephalopathy.
- Hepatitis B in homosexual men: prevalence of infection and factors related to transmission.
- Field use of hair epilation force in nutrition status assessment.
- Dialysis encephalopathy and aluminum exposure: an epidemiologic Analysis.
- Serological testing for hepatitis B in male homosexuals: special emphasis on hepatitis B e antigen and antibody by radioimmunoassay.
- Successful treatment of thrombotic thrombocytopenia Purpura by vincristine.
- Prevalence of hepatitis B in selected Alaskan Eskimo villages.
- Hepatitis B testing in the families and villages of five young eskimos with primary hepatocellular Carcinoma.
- An Acute myeloproliferative disorder characterized by myelofibrosis and blast cells that express phenotypic properties associated with multiple hematopoietic lineages.
- G6PD Huntsville: a new glucose-6-phosphate dehydrogenase associated with chronic hemolytic Anemia.
- Bone marrow origin of a B-cell Lymphoma.
- Phase I-II study of cisplatin, VP-16, MGBG, mitomycin, and vinblastine with radiation therapy for non-small-cell lung Cancer.
- Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
- Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung Cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
- TLE3 as a candidate biomarker of response to taxane therapy.
- The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast Cancer patients with HER2 over-expression that are at an increased risk o...
Schools
Tulane University School Of Medicine
Emory University Hospital
Uab
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Tulane University School of Medicine
Drug Facts
| NPI NUMBER | 1083693154 | |
| NPPES Provider LastName | SCHREEDER | |
| NPPES Provider FirstName | MARSHALL | |
| NPPES Provider ZIPCode | 358052606 | |
| NPPES Provider State | AL | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 3192.0 | |
| Distinct Opioid Count | 9.0 | |
| Opioid Claim Count | 404.0 | |
| Percent Opioid Claims | 12.66 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083693154 |
| Last Name Of The Provider | SCHREEDER |
| First Name Of The Provider | MARSHALL |
| View All |
Similar Doctors
|
|
Dr. Ali B. Hachem, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeremy K. Hon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Manh C. Dang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Waples, MD
This Doctor is OpenDoctor Recommended.
|